CD4 and tuberculosis: Although anti-retroviral drugs lower the risk of TB through immune reconstitution, the risk remains much higher than in HIV-uninfected individuals despite achievement of good CD4 cell recovery, emphasizing the need to implement other preventive interventions such as IPT.